Clinical Trial Update: Pregabalin for Opiate Withdrawal Syndrome [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing pregabalin for opioid withdrawal; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Withdrawal

Drugs mentioned

• Pregabalin (Pregabalin)

Snippet

Sponsor: St. Petersburg Bekhterev Research Psychoneurological Institute | Conditions: Opioid Withdrawal | Phase 4 | Status: COMPLETED